Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Effects of muscarinic M1 receptor stimulation on reinforcing and neurochemical effects of cocaine in rats

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Hippocampal subfield morphology in monozygotic twins discordant for affective disorders

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Plasma psilocin critically determines behavioral and neurobiological effects of psilocybin

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Serotonin release measured in the human brain: a PET study with [11C]CIMBI-36 and d-amphetamine challenge

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Parkinson patients have a presynaptic serotonergic deficit: A dynamic deep brain stimulation PET study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Effects of ketogenic diet and ketone monoester supplement on acute alcohol withdrawal symptoms in male mice

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Glucagon-like peptide-1 receptor regulation of basal dopamine transporter activity is species-dependent

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Cocaine addiction is a chronic illness characterized by maladaptive drug-induced neuroplastic changes that confer lasting vulnerability to relapse. Over several weeks we observed the effects of the M1 receptor-selective agonist VU0364572 in adult male rats that self-administer cocaine in a cocaine vs. food choice procedure. The drug showed unusual long-lasting effects, as rats gradually stopped self-administering cocaine, reallocating behavior towards the food reinforcer. The effect lasted as long as tested and at least 4 weeks. To begin to elucidate how VU0364572 modulates cocaine self-administration, we then examined its long-term effects using dual-probe in vivo dopamine and glutamate microdialysis in nucleus accumbens and medial prefrontal cortex, and ex vivo striatal dopamine reuptake. Microdialysis revealed marked decreases in cocaine-induced dopamine and glutamate outflow 4 weeks after VU0364572 treatment, without significant changes in dopamine uptake function. These lasting and marked effects of M1 receptor stimulation reinforce our interest in this target as potential treatment of cocaine addiction. M1 receptors are known to modulate medium spiny neuron responses to corticostriatal glutamatergic signaling acutely, and we hypothesize that VU0364572 may oppose the addiction-related effects of cocaine by causing lasting changes in this system.

Original languageEnglish
JournalNeuropsychopharmacology
Volume45
Issue number12
Pages (from-to)1994-2002
Number of pages9
ISSN0893-133X
DOIs
Publication statusPublished - Nov 2020

ID: 61340373